What is Mbs Genetics?
Headquartered in Story City, Iowa, Mbs Genetics operates as a specialized entity within the research and development sector. By maintaining a lean workforce of 20 to 49 professionals, the organization has demonstrated remarkable agility, generating annual revenues in the range of 5M to 10M. The company serves as a critical node in the biotechnology supply chain, focusing on high-precision genetic research that demands both technical expertise and substantial infrastructure. Its current market position is defined by a commitment to proprietary methodologies that differentiate its service offerings from larger, more generalized research conglomerates.
How much funding has Mbs Genetics raised?
Mbs Genetics has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Mbs Genetics
PPP
Public-Private Partnership
What's next for Mbs Genetics?
Following this late-stage financing, Mbs Genetics is well-positioned to accelerate its core research objectives and expand its operational footprint. The influx of capital provides the necessary liquidity to enhance laboratory capabilities and potentially pursue strategic partnerships that could broaden its intellectual property portfolio. As the company transitions into this next phase of growth, stakeholders will likely monitor its ability to convert these financial resources into tangible scientific breakthroughs. The focus remains on scaling internal efficiencies while maintaining the rigorous standards required for high-impact genetic development, ensuring the firm remains a formidable player in the evolving biotech ecosystem.
See full Mbs Genetics company page
